FlowCAM 제약 분야 활용 논문 - In-use stability of Rituximab and IVIG during intravenous infusion: Impact of | |
---|---|
작성자 : 삼보과학 작성일 : 2024-08-29 조회수 : 152 | |
파일첨부 : | |
저널명 : International Journal of Pharmaceutics 663 (2024) 124577
저자 : Shavron Hada, I Jeong Shin, Ha Eun Park, Ki Hyun Kim, Kwang Joon Kim, Seong Hoon Jeong, Nam Ah Kim ABSTRACT
This study investigates the impact of intravenous (IV) infusion protocols on the stability of Intravenous Immu- noglobulin G (IVIG) and Rituximab, with a particular focus on subvisible particle generation. Infusion set based on peristaltic movement (Medifusion DI-2000 pump) was compared to a gravity-based infusion system (Accu- Drip) at different flow rates. The impacts of different diluents (0.9 % saline and 5.0 % dextrose) and plastic syringes with or without silicone oil (SO) were also investigated. The results from the aforementioned particular case demonstrated that peristaltic pumps generated high levels of subvisible particles (prominently < 25 µm), exacerbated by increasing flow rates, specifically in formulations lacking surfactants. Other factors, such as diluent type and syringe composition, also increased the number of subvisible particles. Strategies that can help overcome these complications include surfactant addition as well as the use of SO-free syringes and a gravity infusion system, which aid in reducing particle formation and preserving antibody monomer during adminis- tration. Altogether, these findings highlight the importance of the careful selection of formulations and infusion protocols to minimize particle generation during IV infusion both for patients’ safety and treatment efficacy. |
이전글 | |
---|---|
다음글 | FlowCAM 제약 분야 활용 논문 - Assessment of subvisible particles in biopharmaceuticals with image feature ex |
|
고객지원 > 종합자료실